NALOXONE HYDROCHLORIDE INJECTION USP
Google image searchProduct monograph
Active ingredient
naloxone hydrochloride, 0.4 MG/ML
DIN: 02548194
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR, SUBCUTANEOUS
Schedule: Ethical
Company: STERINOVA INC.
Date: 26-SEP-2024
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AB — Antidotes (ATC, ATC/DDD)
- V03AB15 — NALOXONE (ATC/DDD)
Reference brand drug: Narcan
Pharmaceutical standard: USP
